These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer. Akl EA; Kahale L; Sperati F; Neumann I; Labedi N; Terrenato I; Barba M; Sempos EV; Muti P; Cook D; Schünemann H Cochrane Database Syst Rev; 2014 Jun; (6):CD009447. PubMed ID: 24966161 [TBL] [Abstract][Full Text] [Related]
5. No difference in risk for thrombocytopenia during treatment of pulmonary embolism and deep venous thrombosis with either low-molecular-weight heparin or unfractionated heparin: a metaanalysis. Morris TA; Castrejon S; Devendra G; Gamst AC Chest; 2007 Oct; 132(4):1131-9. PubMed ID: 17646239 [TBL] [Abstract][Full Text] [Related]
6. Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer. Akl EA; Labedi N; Terrenato I; Barba M; Sperati F; Sempos EV; Muti P; Cook D; Schünemann H Cochrane Database Syst Rev; 2011 Nov; (11):CD009447. PubMed ID: 22071865 [TBL] [Abstract][Full Text] [Related]
7. How frequently is venous thromboembolism in heparin-treated patients associated with heparin-induced thrombocytopenia? Levine RL; McCollum D; Hursting MJ Chest; 2006 Sep; 130(3):681-7. PubMed ID: 16963663 [TBL] [Abstract][Full Text] [Related]
8. Should patients be informed about the risk of heparin-induced thrombocytopenia before prolonged low-molecular-weight heparin thromboprophylaxis post-trauma/orthopedic surgery? Lubenow N; Hinz P; Ekkernkamp A; Greinacher A Eur J Haematol; 2007 Sep; 79(3):187-90. PubMed ID: 17655709 [TBL] [Abstract][Full Text] [Related]
9. The severity of trauma determines the immune response to PF4/heparin and the frequency of heparin-induced thrombocytopenia. Lubenow N; Hinz P; Thomaschewski S; Lietz T; Vogler M; Ladwig A; Jünger M; Nauck M; Schellong S; Wander K; Engel G; Ekkernkamp A; Greinacher A Blood; 2010 Mar; 115(9):1797-803. PubMed ID: 19965682 [TBL] [Abstract][Full Text] [Related]
11. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Warkentin TE; Greinacher A Chest; 2004 Sep; 126(3 Suppl):311S-337S. PubMed ID: 15383477 [TBL] [Abstract][Full Text] [Related]
12. Decreased prevalence of heparin-induced thrombocytopenia with low-molecular-weight heparin and related drugs. Walenga JM; Jeske WP; Prechel MM; Bacher P; Bakhos M Semin Thromb Hemost; 2004 Feb; 30 Suppl 1():69-80. PubMed ID: 15085468 [TBL] [Abstract][Full Text] [Related]
13. Incidence and diagnosis of heparin-induced thrombocytopenia (HIT) in patients with traumatic injuries treated with unfractioned or low-molecular-weight heparin: a literature review. Bloemen A; Testroote MJ; Janssen-Heijnen ML; Janzing HM Injury; 2012 May; 43(5):548-52. PubMed ID: 21640991 [TBL] [Abstract][Full Text] [Related]
14. Impact of the patient population on the risk for heparin-induced thrombocytopenia. Warkentin TE; Sheppard JA; Horsewood P; Simpson PJ; Moore JC; Kelton JG Blood; 2000 Sep; 96(5):1703-8. PubMed ID: 10961867 [TBL] [Abstract][Full Text] [Related]
15. Incidence and economic implications of heparin-induced thrombocytopenia in medical patients receiving prophylaxis for venous thromboembolism. Creekmore FM; Oderda GM; Pendleton RC; Brixner DI Pharmacotherapy; 2006 Oct; 26(10):1438-45. PubMed ID: 16999654 [TBL] [Abstract][Full Text] [Related]
17. [Heparin-induced thrombocytopenia as a complication of postoperative prevention of thromboembolism with unfractionated heparin/low molecular weight heparin after hip and knee prosthesis implantation]. Mahlfeld K; Franke J; Schaeper O; Kayser R; Grasshoff H Unfallchirurg; 2002 Apr; 105(4):327-31. PubMed ID: 12066471 [TBL] [Abstract][Full Text] [Related]
18. Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis. Chande N; McDonald JW; Macdonald JK Cochrane Database Syst Rev; 2008 Apr; (2):CD006774. PubMed ID: 18425969 [TBL] [Abstract][Full Text] [Related]
19. Fondaparinux for thromboembolic treatment and prophylaxis of heparin-induced thrombocytopenia. Efird LE; Kockler DR Ann Pharmacother; 2006; 40(7-8):1383-7. PubMed ID: 16788093 [TBL] [Abstract][Full Text] [Related]
20. The incidence of heparin-induced thrombocytopenia in medical patients treated with low-molecular-weight heparin: a prospective cohort study. Prandoni P; Siragusa S; Girolami B; Fabris F; Blood; 2005 Nov; 106(9):3049-54. PubMed ID: 16030191 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]